Indivior PLC (INDV)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	510	319	316	774	1,102	858
Short-Term Investments	-	-	84	109	-	-
Trading Asset Securities	-	1	10	10	-	-
Cash & Short-Term Investments	510	320	410	893	1,102	858
Cash Growth	34.56%	-21.95%	-54.09%	-18.97%	28.44%	-19.06%
Accounts Receivable	240	254	254	220	202	179
Other Receivables	3	34	-	5	13	7
Receivables	243	288	254	225	215	186
Inventory	149	178	142	114	95	93
Prepaid Expenses	28	31	23	14	18	17
Other Current Assets	21	12	434	13	14	33
Total Current Assets	951	829	1,263	1,259	1,444	1,187
Property, Plant & Equipment	152	136	115	85	95	103
Long-Term Investments	27	27	41	98	-	-
Goodwill	-	2	2	-	-	-
Other Intangible Assets	7	175	232	70	82	62
Long-Term Deferred Tax Assets	270	268	267	219	105	75
Other Long-Term Assets	45	29	28	38	106	104
Total Assets	1,452	1,466	1,948	1,769	1,832	1,531
Accounts Payable	50	63	39	33	26	20
Accrued Expenses	855	734	704	584	694	108
Current Portion of Long-Term Debt	18	18	3	3	3	4
Current Portion of Leases	11	10	9	8	8	8
Current Income Taxes Payable	17	11	18	9	7	15
Other Current Liabilities	105	110	533	382	66	444
Total Current Liabilities	1,056	946	1,306	1,019	804	599
Long-Term Debt	308	315	236	237	239	230
Long-Term Leases	29	31	34	29	36	43
Other Long-Term Liabilities	316	379	372	433	550	573
Total Liabilities	1,709	1,671	1,948	1,718	1,629	1,449
Common Stock	62	62	68	68	70	73
Additional Paid-In Capital	101	13	11	8	7	6
Retained Earnings	-388	1,044	1,244	1,303	1,438	1,311
Comprehensive Income & Other	-32	-1,324	-1,323	-1,328	-1,312	-1,308
Shareholders' Equity	-257	-205	-	51	203	82
Total Liabilities & Equity	1,452	1,466	1,948	1,769	1,832	1,531
Total Debt	366	374	282	277	286	285
Net Cash (Debt)	144	-54	128	616	816	573
Net Cash Growth	46.94%	-	-79.22%	-24.51%	42.41%	-25.29%
Net Cash Per Share	1.13	-0.41	0.90	4.43	5.37	3.91
Filing Date Shares Outstanding	124.77	124.97	136.35	136.48	140.49	146.73
Total Common Shares Outstanding	125	124.97	136.53	136.48	140.49	146.73
Working Capital	-105	-117	-43	240	640	588
Book Value Per Share	-2.06	-1.64	-	0.37	1.44	0.56
Tangible Book Value	-264	-382	-234	-19	121	20
Tangible Book Value Per Share	-2.11	-3.06	-1.71	-0.14	0.86	0.14
Land	83	91	69	51	55	55
Machinery	76	107	94	80	77	73

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q